Arthur joined Gilde Healthcare in 2001 and was part of the team that started the Venture&Growth strategy.

He oversees investments across our Venture&Growth fund in sectors such as biopharmaceuticals, medtech, diagnostics, and digital health.

Previously, Arthur was a Research Fellow at the Leiden/Amsterdam Centre for Drug Servies and TNO. He holds a Master’s degree in Biopharmaceutical Sciences from Leiden University, the Netherlands.